DÍVIDA Alterar Data
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amgen USD 54.6B 17M 2025-12
Ardelyx USD 208.26M 653K 2026-03
Astellas Pharma JPY 831.43B 83.94B 2025-03
AstraZeneca USD 33.92B 4.3B 2026-03
Bayer EUR 36.45B 2.93B 2025-12
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Celltrion KRW 160.58B 733.3M 2026-03
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.36M 79K 2026-03
Exelixis USD 169.54M 3.5M 2026-03
Fresenius Medical Care EUR 11.03B 233.8M 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 54.99B 7.05B 2026-03
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Moderna USD 1.3B 7M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 8.2M 554K 2026-03
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 47.54M 1.88M 2026-03
Prothena USD 7.65M 1.43M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Qiagen NV USD 1.65B 165.82M 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Sartorius EUR 4.05B 248.8M 2026-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tectonic Therapeutic USD 876K 115K 2024-12
Tilray USD 640.95M 35.17M 2022-06
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03